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Department of Physiology and Biophysics, State University of New York, Buffalo, New YorkABSTRACT The gating isomerization of neuromuscular acetylcholine receptors links the rearrangements of atoms at two
transmitter-binding sites with those at a distant gate region in the pore. To explore the mechanism of this reversible process,
we estimated the gating rate and equilibrium constants for receptors with point mutations of a-subunit residues located between
the binding sites and the membrane domain (N95, A96, Y127, and I49). The maximum energy change caused by a side-chain
substitution at aA96 was huge (~8.6 kcal/mol, the largest value measured so far for any a-subunit amino acid). A F-value anal-
ysis suggests that aA96 experiences its change in energy (structure) approximately synchronously with residues aY127 and
aI49, but after the agonist molecule and other residues in loop A. Double mutant-cycle experiments show that the energy
changes at aA96 are strongly coupled with those of aY127 and aI49. We identify a column of mutation-sensitive residues in
the a-subunit that may be a pathway for energy transfer through the extracellular domain in the gating isomerization.INTRODUCTIONNicotinic acetylcholine (ACh) receptors (AChRs) are ion
channels that isomerize (gate) between stable conformations,
R4R*. The R shape has a low affinity for the transmitter
(ACh) and a nonconducting pore, and the R* shape has
a high affinity for ACh and a pore that readily conducts
monovalent cations. At the nerve-muscle synapse, two trans-
mitter molecules bind to each AChR to increase the R4R*
equilibrium constant and promote the entry of Naþ into (and
the depolarization of) muscle cells (1–4). We, as well as
other investigators, are interested in understanding the
mechanisms by which ACh and other agonists increase the
R4R* equilibrium constant and hence the probability that
a remote ion channel domain will adopt an ion-conducting
conformation. Our approach is to estimate the spatial distri-
bution and timing of energy changes within the protein as
determined from isomerization rate constants of mutant
AChRs.
Ligand-binding and channel-gating are coupled energeti-
cally (Fig. 1) (5). In the absence of an external energy source,
and with two equivalent transmitter-binding sites (6), the
ratio of the gating equilibrium constants with two versus
zero bound agonist molecules [(E2/E0) is equal to the square
of the ratio of the R/R* equilibrium dissociation constants
(Kd/Jd)
2]. Although it has been shown in wild-type (wt)
AChRs (E0 << E2) that the end states and conformational
pathway of the R4R* isomerization are essentially the
same whether or not agonists occupy the transmitter-binding
sites (7), it has also been demonstrated that many non-
binding-site mutations change E2 by a parallel change in
E0 and do not alter the Kd/Jd ratio.Submitted March 8, 2010, and accepted for publication May 6, 2010.
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0006-3495/10/08/0798/10 $2.00In adult mouse AChRs, the gating equilibrium constant is
much larger when both binding sites are occupied by ACh
(E2
ACh z 28) (8–10) than when they are not (E0 z 6.5 
107) (6). Since energy is proportional to the logarithm of
an equilibrium constant, this E2/E0 ratio (~43 million) corre-
sponds to a 10.4 kcal/mol increase in the relative stability
of conducting (R*) versus nonconducting (R) AChRs, with
ACh versus without any agonists at the binding sites. By the
same token, between R and R* the equilibrium dissociation
constant (for ACh) decreases from ~140 mM (Kd) to ~20 nM
(Jd). This ~6600-fold change in affinity corresponds to an
increase in ligand-binding energy of 5.2 kcal/mol per
transmitter-binding site.
The changes in energy (structure) that comprise the global,
gating isomerization of an AChR are neither uniform nor
synchronous (11). The increase in agonist affinity involves
rearrangements of atoms (water, protein, and perhaps ions)
at the transmitter-binding sites that occur at the start, and
the change in ionic conductance involves rearrangements
of atoms at the gate region of the pore that occur at the
end of the channel-opening process (11,12). The trans-
mitter-binding sites and the gate are separated by ~5 nm
(13) and the affinity change may precede the conductance
change by ~1 ms (8,14). A change in the structure of a residue
(with respect to its local environment) between R andR* can
be manifested as a change in the relative free energies of
these end states. That is, if a side-chain substitution changes
the gating equilibrium constant (the ratio of the forward/
backward isomerization rate constants), then the residue
must change its R versus R* relative energy (structure) at
some point within the reaction. The extent to which a
mutation changes the forward versus the backward rate
constant is given by the parameter F, which is the position
in the reaction when such an energy (structure) change
occurs (1-to-0, early-to-late).doi: 10.1016/j.bpj.2010.05.008
FIGURE 2 Location and structure of residues. (A) Left: Torpedo AChR
structure determined by cyroelectron microscopy (accession number
2BG9.pdb (13)). Shown as spheres in each of the two a-subunits are
(blue) aW149 (at the transmitter-binding site) and (red) aI49 (loop 2),
aA96 (loop A), and aY127 (b-strand 6). Horizontal lines approximately
mark the membrane. The M2 transmembrane helix lines the ion permeation
pathway and the M4 helix faces the lipids. Right: Mouse a-subunit extracel-
lular domain fragment (accession number 2QC1.pdb (23)). A bound toxin
molecule has been removed for clarity. The highlighted residues (red,
bold) are aN95, aA96, aY127, and aI49. Five loops are color-coded:
cyan, loop C; blue, loop B; yellow, loop A; tan, loop 2; green, loop 7 (cys
loop). (B) Electron density map near the a(A96-Y127) region (from
2QC1.pdb). Left: Residues aA96 and aY127 are shown as sticks according
to their position in 2QC1.pdb. Right: The same as the left except that aY127
is shown as an alternate rotamer, approximately filling an unoccupied region
of the electron density map near aA96.
FIGURE 1 Cyclic activation model for AChRs. Boxed letters are the
stable end-states (R, low affinity and closed channel; R*, high affinity and
open channel; A, the agonist). Arrows indicate the intermediate microstates
(horizontal: ligand-binding; vertical: protein isomerization) that are too brief
to be detected by our instrument. Equilibrium constants for each step: E,
isomerization with zero, one, or two bound agonists; Kd, dissociation
constant of R; Jd, dissociation constant of R*. For mouse, adult-type AChRs
the two binding sites have approximately equal affinities for ACh (Kd ¼
140 mM and Jd ¼ 20 nM). The energy between any two stable states is
independent of the connecting pathway, hence E2/E0 ¼ (Kd/Jd)2.
Acetylcholine Receptor Gating 799A map of the energy changes and F-values for adult
mouse neuromuscular AChR residues suggests that there
are some amino acids in the extracellular domain of the
a-subunit that when mutated exhibit a particularly large
range of gating equilibrium constants (i.e., have a particularly
large energy sensitivity) and change structure relatively early
in the gating process (12). Here we examine a hot spot in this
population that we speculate is an important element in the
pathway for energy transfer between the binding sites and
the gate.
In this study we focused on residues aN95 and aA96 (in
loop A), aI49 (in loop 2), and aY127 (on b-strand 6)
(Fig. 2). This general region of the AChR has previously
been examined in some detail. Mutations of loop A residue
aD97 mostly increase E2 (by a parallel increase in E0) and
elicit an early energy change but have little effect on Kd
for ACh (15). This position (in all subunits) has been
shown to influence channel conductance (16). Loop 2
residues have been shown to be important elements in
the isomerization pathway (13,17,18). In the AChR, resi-
dues 45–48 have a significant effect on E2 and change
energy early, but after aD97 (17). Mutations of loop 2
residue aE45 have a particularly large effect on E2. This
residue probably does not form a salt bridge with pre-
M1 residue R209 (19) (but see Lee and Sine (9)). The
b-strand 6-amino-acid residue aY127 has been studied
by two groups (20,21). Substitutions of this position
have a huge effect on E2 (by a parallel change in E0)
and a F-value similar to that of loop 2, and are coupled
energetically with those of residues in the complementary
d/3-subunits. The residues adjacent to aY127 are either at
one end of loop 7 (the cys loop; aC128) (22) or bind
a structural water whose disposition may be important in
the gating isomerization (aS126) (15,23). The next residue
in sequence, aK125, is a possible binding site for allosteric
modulators (24).MATERIALS AND METHODS
Mutagenesis and expression
Mutations were made to mouse AChR subunit cDNA using the QuikChange
site-directed mutagenesis kit (Stratagene, La Jolla, CA) and verified by
nucleotide sequencing. Human embryonic kidney fibroblast cells (HEK
293) were transiently transfected by calcium phosphate precipitation. Cells
were treated with ~0.7 mg total DNA per 35 mm culture dish in the ratio
of 2:1:1:1 (a/b/d/3) for ~16 h. Electrophysiological recordings were made
24–48 h later.
To make hybrid AChRs with only one of the two a-subunit residues
mutated, cells were transfected with both wt and mutant a-subunit (plus
wt b-, 3-, and d-subunits) cDNAs. Accordingly, AChRs with zero, one, or
twomutated a-subunits were expressed, with each construct having a distinct
single-channel kinetic signature (25).Electrophysiology
Recordings were performed in a cell-attached patch configuration at 22C.
The bath and pipette solutions were Dulbecco’s phosphate-buffered salineBiophysical Journal 99(3) 798–807
800 Cadugan and Auerbachcontaining (mmol/L) 134 NaCl, 0.9 CaCl2, 2.7 KCl, 1.5 KH2PO4,
0.5 MgCl2, and 8.1 Na2HPO4 (pH 7.3). Pipettes were pulled from borosili-
cate capillaries to a resistance of ~10 MU and coated with Sylgard (Dow
Corning, Midland, MI). The pipette potential was held at þ70 mV, which
corresponds to a membrane potential of approximately 100 mV. Single-
channel currents were recorded using a PC-505 amplifier (Warner Instru-
ment Corp., Hamden, CT) with low-pass filtering at 20 kHz. The currents
were digitized at 50 kHz using a SCB-68 acquisition board (National
Instruments, Austin, TX) and QuB software (www.qub.buffalo.edu).
In some experiments, agonist (500 mM acetylcholine or 20 mM choline)
was added only to the pipette solution as indicated. These concentrations are
approximately five times the R-conformation equilibrium dissociation
constant (Kd) (26).Determination of rate constants
The isomerization rate constants were estimated with the use of QuB soft-
ware. Clusters of single-channel R4R* gating activity were selected by
eye. Clusters were idealized using the segmental k-means algorithm with
a two-state, C(losed)4O(pen) model (27). The forward and backward
isomerization rate constants were estimated from the interval durations by
using a two-state model and a maximum-interval likelihood algorithm after
imposing a dead time (and missed event correction) of 50 ms (28). The
isomerization equilibrium constant is the ratio of these rate constants, and
the corresponding energy change (kcal/mol) is 0.59 times the natural
logarithm of the equilibrium constant.Thermodynamic cycle
The function of AChRs is well described by the thermodynamic cycle shown
in Fig. 1. Subsets of the possible stable states of this scheme are apparent
under different experimental conditions. For example, by nearly saturating
the binding site with agonist we isolate A2R4A2R*, and by removing
agonist entirely we isolate R4R*. These are the two strategies we used
to directly measure the di- and unliganded gating equilibrium constants E2
and E0. In wt AChRs, E2
ACh z 28 (8,9,14,15) and E2
choline z 0.046
(29). To measure the fold change in E2 caused by a side-chain substitution,
we used either of these agonists depending on whether the mutation
increased (choline) or decreased (ACh) E2.
For some of the point mutations at position aA96 (in both a-subunits),
E2 was so great that it was difficult or impossible to measure gating events
directly with choline (that is, the forward isomerization rate constant
was>~10,000 s1). For these constructs we measured either the gating equi-
librium constant using diliganded hybrid AChRs (in which only one
a-subunit had the mutation) or unliganded AChRs (E0). For hybrids, if
the contribution of the two mutations is equal and independent, then the
fold change of the hybrid is the square root of the fold change of the double
mutant. We tested this for the aA96M mutation and found equal and inde-
pendent contributions from each of the hybrid mutant receptors.
The second approach was to measure E0. According to the thermody-
namic cycle in Fig. 1, mutations that do not affect the R/R* affinity ratio
alter E2 by a parallel change in E0; that is, the fold change in E0 is exactly
the same as that in E2. It was necessary to measure E0 instead of E2 because
the aA96H mutation, for example, increases E0 by >100,000-fold. From
this value we predict that the forward isomerization rate constant for this
construct would be ~5  109 s1 with ACh and ~1  107 s1 with choline,
both of which would result in shut interval durations that are far too brief to
be detected by our experimental apparatus.
To gain a more accurate measure of E0, we increased this value for
the construct by adding the energetically independent mutation 3L269T
(in the pore-lining M2 helix), which by itself increases E2 by 45-fold
(Table 1). This is in agreement with the literature value of 41-fold (30).
To test the effect of this background mutation on E0, we measured E0 for
the aA96D mutant with and without the 3L269T background mutant. The
E0 value for the aA96D mutant alone was 0.01. The measured E0 valueBiophysical Journal 99(3) 798–807for the aA96D þ 3L269T double-mutant construct was 0.56, which is
only 1.2-fold higher than predicted from the E2 measurement. This result
supports the hypothesis that the fold change in E2 caused by the background
mutation was caused by a parallel change in E0 (3L269T does not alter the
affinity ratio).
We derived two parameters from the rate constants measured for a family
of mutations at a particular position. The free-energy change between R
and R* caused by the mutations was calculated as (kcal/mol): 0.59ln
(Emutant/Ewt). The first parameter of interest is the range-energy, which is
the free-energy difference between the side chains that yield the smallest
and largest gating equilibrium constants for that residue. The second param-
eter of interest isF, which is the slope of the rate-equilibrium (R/E) relation-
ship (a log-log plot of forward isomerization rate constant versus the
equilibrium constant).Mutant cycle analysis
The double-mutant cycle analysis approach was used to determine the
interaction energies for seven different pairs of residues using 16 different
side-chain combinations. A mutant cycle analysis determines the extent to
which the energy of a double mutation is not the sum of the energies
of the single mutations (31). The coupling free energy is defined as
DDG (kcal/mol) ¼ 0.59ln(Eobserved/Epredicted), or DDG (kcal/mol) ¼
0.59ln[(Edouble mutant)(Ewt)/(Emutant 1)/(Emutant 2)].
R/E plots and mutant cycles are perturbation analyses. Neither method
addresses what happens in the unperturbed (wt) condition. The range-energy
of an R/E plot gives a lower limit for the energetic sensitivity of a position to
mutation, and the coupling-range-energy (from a series of mutant cycles)
gives a lower limit for the interaction energy between a residue pair. That is,
adding more mutations may increase but cannot decrease these parameters.RESULTS
aA96
We mutated aA96 to all 19 natural amino acids. Table 1 and
Fig. 3 show the isomerization rate and equilibrium constants
estimated (by single-channel analysis) for AChRs having
side-chain substitutions in both a-subunits. Only three of
the mutations (G, T, and S) decreased the diliganded
R4R* equilibrium constant (E2) compared to wt AChRs
activated by ACh. The largest reduction in E2 was observed
for the mutant aA96S (14-fold). Eight mutations (P, M, K,
R, L, E, C, and V) increased E2 by a small to moderate
amount, and for these we used the partial-agonist choline
to activate the AChRs.
The remaining eight aA96 mutations increased E2 beyond
the range that we could measure using choline, so we applied
two alternative approaches. AChRs have two a-subunits.
First, we measured E2 (with choline) in hybrid AChRs that
had only one of the two aA96 residues mutated (25). Our
expectation was that the energetic consequence of one muta-
tion would be less than that of two, and therefore we would
be able to measure E2 in the hybrids. As a control, we quan-
tified a hybrid E2-value for aA96M, a mutation whose
effects had already been measured for doubly mutated
AChRs. We observed only one hybrid aA96M mutant pop-
ulation of clusters, which had an E2-value that was approxi-
mately halfway (on a log scale) between the double mutant
and wt constructs (Fig. 4, A–C). This result indicates that
TABLE 1 Gating rate and equilibrium constants for AChRs with mutations at positions aN95, aA96, and aI49
Construct Agonist f SE b SE E Fold-change n
wt ACh 48,000 - 1700 - 28.2 1 -
wt Cho 120 - 2583 - 0.046 1 -
A96C Cho 5360 370 979 130 5.47 118 3
A96Dþ3L269T None 3410 100 6150 870 0.56 19,100 3
A96D None 101 8 9840 1600 0.01 15,800 3
A96E Cho 8910 1900 456 130 19.5 420 3
A96Fþ3L269T None 60 5 4160 1100 0.01 497 4
A96F hybrid Cho 1370 44 1660 290 0.83 17.8 3
A96G ACh 15,800 970 1110 160 14.2 0.504 3
A96Hþ3L269T None 5800 570 1710 230 3.38 117,000 4
A96Iþ3L269T None 1290 180 10,800 1400 0.12 4100 4
A96K Cho 1650 10 3020 370 0.55 11.8 3
A96L Cho 6380 770 2770 180 2.31 49.6 3
A96M Cho 1790 80 5230 480 0.34 7.36 5
A96Nþ3L269T None 738 100 6250 1200 0.13 4071 3
A96P Cho 255 1 2920 41 0.09 1.88 3
A96Q hybrid Cho 2540 420 1490 200 1.71 36.8 3
A96R hybrid Cho 1790 310 1720 200 1.04 22.3 3
A96S ACh 8020 1100 3970 750 2.02 0.07 3
A96T ACh 9630 340 1760 240 5.47 0.19 3
A96V Cho 5750 1200 629 140 9.15 197 3
A96Wþ3L269T None 1620 75 4740 310 0.34 11,800 3
A96Yþ3L269T None 2800 500 5140 410 0.55 18,800 3
I49A Cho 293 22 17,700 710 0.02 0.36 3
I49C Cho 775 58 2920 280 0.27 5.71 3
I49D Cho 2690 310 3520 860 0.76 16.4 3
I49F Cho 5180 970 2130 340 2.43 52.3 3
I49H Cho 1990 240 3130 290 0.64 13.7 4
I49K Cho 1590 44 4860 50 0.33 7.03 3
I49R Cho 1240 64 2700 150 0.46 9.86 3
I49Y Cho 1290 230 3040 340 0.42 9.12 3
N95Q Cho 220 37 3090 130 0.07 1.54 3
N95W ACh 287 31 4510 250 0.06 0.0023 3
3L269T Cho 666 170 327 60 2.04 45.0 4
f, forward R/R* isomerization rate constant (s1); b, backward R)R* isomerization rate constant (s1); SE, standard error of the mean for n patches; E,
isomerization equilibrium constant (¼f/b); fold-change, Emut/Ewt. Agonists: ACh, 0.5 mM acetylcholine; cho, 20 mM choline; none, spontaneous activity only.
Acetylcholine Receptor Gating 801each of the two aA96M mutations makes an approximately
equal energetic contribution to gating. We next examined
three additional, larger gain-of-function hybrid aA96 con-
structs (F, Q, and R) and again observed only a single hybrid
population of currents. The rate and equilibrium constants
for these hybrids were added to the R/E plot for aA96
(Fig. 3 A). For all agonist-activated aA96 mutants combined,
the slope of the R/E relationship (F) was 0.79 5 0.05.
In the second approach used to quantify the large gain-of-
function aA96 mutants, we measured their energetic conse-
quences in spontaneously active AChRs (Fig. 4, D–F). If the
aA96 mutations do not affect the R versus R* affinity ratio
(see below), then the magnitude of the fold change in E2
should be the same as the magnitude of their effect on the
unliganded equilibrium constant (E0) (Fig. 1) (7). We
measured E0 directly for six different aA96 mutants (N, I,
W, D, Y, and H). As a control, we first measured both E2
and E0 for the mutant aA96F. Using the value E0 ¼ 6.5 
107 for the wt (6), the energy change calculated from thefold-increase in E0 for this mutant (3.7 kcal/mol) is similar
to that calculated from the fold change in E2, assuming
that the two hybrids are equivalent (3.4 kcal/mol). This
observation indicates that the increase in E2 was caused
mainly by a parallel increase in E0, and the R*/R affinity
ratio for ACh was not altered significantly by this mutation.
For all of the tested mutants, the largest fold-increase in E0
was observed for aA96H (~117,000-fold; ~6.9 kcal/mol).
Overall, the range in fold-change of the R4R* equilib-
rium constant for the different aA96 side chains (S-to-H)
was 1.6  106, which corresponds to a range-energy of
~8.4 kcal/mol (for two a-subunits). To our knowledge, this
is the largest energy change observed so far for any
a-subunit residue. We plotted the energetic consequence of
each aA96 mutation as a function of the size or hydropho-
bicity of the substituted side chain (see Fig. S1 in the
Supporting Material). There was a small tendency for the
gating equilibrium to increase with increasing side-chain
volume.Biophysical Journal 99(3) 798–807
FIGURE 3 R/E constant analysis of aA96, aN95, aI49. (A) R/E plot for
dilganded gating of AChRs with mutations at position aA96. The forward
(channel-opening) isomerization rate and the gating equilibrium constants
for each mutation were normalized by the wt value (triangle; Table 1). Solid
circles: choline-activated; open circles: ACh-activated; *, hybrid AChRs
with only one mutant a-subunit. The slope of the line (F) is 0.79 5 05
(SE). (B) Example currents clusters for each aA96 mutant construct
(R* is down).
802 Cadugan and AuerbachWe next tested whether the mutation aA96G alters the
kinetics or equilibrium constant for ACh binding to R
(Fig. S2). We found that the single-site association rate
constant (kþ), dissociation (k) rate constant, and equilib-
rium dissociation constant (Kd) were unchanged by the
mutation. This result and the above observation that the
agonist affinity ratio was not altered by the Phe mutation
suggest that none of the aA96 mutants changed the equilib-
rium dissociation constants for ACh binding to either the R
(Kd) or R* (Jd) conformation.aI49 and aN95
We also measured the energetic consequences (range-energy
and F) of mutations of two residues near aA96, aN95 (adja-
cent in sequence), and aI49 (near in structure) (Fig. 5). Two
other nearby residues have already been investigated thor-Biophysical Journal 99(3) 798–807oughly (all 19 amino acid substitutions): aY127 (range-
energy ¼ 7.4 kcal/mol, F ¼ 0.77) (21) and aD97 (range-
energy ¼ 3.5 kcal/mol, F ¼ 0.93) (15) (see Fig. 2 A, left).
aI49 was mutated to eight different side chains. The
range-energy here was 2.9 kcal/mol, which is similar to
the value for aD97 but much smaller than that for aA96.
The F-value for aI49 (0.71 5 0.13) was not significantly
different from that for aA96. aN95 was mutated to W and
Q. The Q mutation produced AChRs with nearly wt gating
kinetics, but the W mutation greatly reduced E2. The slope
of the R/E plot for aN95 was 0.865 0.03. The range-energy
for this position is 1.7 kcal/mol.
In summary, for the group of five neighboring a-subunit
residues (95-96-97 (loop A), 127 (b strand 6), and 49
(loop 2)), the F-values were similar for 95 and 97 (~0.9),
and for 49, 96, and 127 (~0.75). Both 96 and 127 experi-
enced very large energy changes in gating.Mutant cycle analyses
We used mutant cycle analyses to probe the extent to which
energy changes consequent to mutation of aA96, aY127,
and aI49 are coupled. The results are shown in Table 2
and Fig. S3. For three different 96/127 side-chain pairs, the
interaction energies ranged from 3.4 kcal/mol (Cys/Cys)
to þ2.4 kcal/mol (Tyr/Ala). Thus, the 96/127 side-chain
pairs were strongly coupled, by up to 5.8 kcal/mol. Similar
experiments for four different 96/49 mutant pairs showed
that for these positions the coupling energy ranged from
þ0.5 kcal/mol (Tyr/Leu) to þ6.1 kcal/mol (Cys/Cys). These
results indicate that position a96 can interact strongly with
both a127 and a49. Of interest, four different 127/49 side-
chain pairs (K/D, I/Y, D/K, and C/C) did not show a signifi-
cant interaction energy.
Three observations noted above suggest that the aA96
side chain does not interact energetically with transmitter
molecules at the binding site: 1), the rate and the equilibrium
constants measured with choline and ACh share the same
R/E relationship; 2), the fold increases in E2 and E0 are
similar for the aA96 mutants (i.e., there is no change in
the affinity ratio for the agonist); and 3), the mutation
aA96G does not alter the R affinity for ACh. To explore
this issue further, we used mutant cycle analyses to test for
energetic coupling between aA96 and two binding-site resi-
dues: aW149 and aY93 (Table 2 and Fig. S3). The 96/149
interaction energy was only þ0.1 kcal/mol (Asn/Ser) and
the 96/93 interaction energy was either þ0.2 kcal/mol
(His/His) or 0.3 kcal/mol (Arg/Arg). These results suggest
that aA96 does not interact energetically with these binding-
site residues.DISCUSSION
The main experimental findings in this work were that the
aA96 side chain 1), experiences extremely large energy
FIGURE 4 Analysis of large gain-of-function
aA96 mutants. (A) Continuous current trace from
a cell transfected with aA96M plus wt a-, b-, d-,
and 3-subunit cDNAs. Three types of cluster are
apparent, generated by wt (aA96þ aA96),
double-mutant (aA96MþaA96M), and hybrid
(aA96þaA96M) AChRs. (B) Histogram of
inverse mean closed interval duration for all clus-
ters in the patch shown in panel A. The three
populations are (left to right) double mutant,
hybrid, and wt. (C) R/E plot for clusters from the
three populations shown in panel A. The gating
equilibrium constant of the hybrid population is
(on a log scale) about halfway between the wt
and double-mutant populations, indicating that
the aA96M mutation had approximately equal
energetic effects in each subunit. (D) Spontaneous
currents from the double aA96H mutant (no
agonist in the bath or pipette). Each cluster reflects
the gating activity of an individual AChR. The
background construct had the mutation 3L269T
(in the M2 helix of the 3-subunit). (E) Example
spontaneous clusters at higher resolution. (F) R/E
plot for unliganded gating of aA96 mutants. The
slope of the line (F) ¼ 0.865 0.20.
Acetylcholine Receptor Gating 803changes in the R4R* isomerization; 2), is strongly coupled
energetically with residues aY127 and aI49 but not directly
with the transmitter-binding site; and 3), has a F-value that
is lower than its loop A neighbors but similar to those for
residues in the lower part of the extracellular domain of the
a-subunit.
Maps of the energy changes andF-values for some impor-
tant residues in the a-subunit extracellular domain are shown
in Fig. 6. aA96 and aY127 comprise a hot spot (two residues
with the largest R versus R* energy change and are energet-
ically linked) in a chain of residues between the transmitter-
binding site and the M2 transmembrane helix that all can
experience a large (R4 kcal/mol) R versus R* energy
change in the gating isomerization. A change in energy re-
flects a change in structure, and the amino acids that show
the largest energy changes form approximately a column in
each a-subunit alongside the complementary 3/d-subunit.
This result indicates that there is an energetically significantstructural change in these regions of the protein between
R and R*.
We estimate that the range-energy for position aA96 is
8.4 kcal/mol (S-to-H substitution in both a-subunits). The
results indicate that the energy change at this position is
entirely attributable to a change in the spontaneous gating
equilibrium constant E0. The aA96 range-energy is larger
than the previous point-mutation record (7.4 kcal/mol, a
290,000-fold change in equilibrium constant) for a D-to-F
substitution at aY127 (21). These two residues are by far
the most energetically sensitive ones that have been identi-
fied in the a-subunit in AChR gating. For comparison, the
range-energy for two agonist molecules (compared to
none) is 10.4 kcal/mol for ACh, 9.4 kcal/mol for carbamyl-
choline, and 6.6 kcal/mol for choline (6,7,25). That is, an
S-to-H substitution at aA96 has nearly the same effect on
the channel open probability as does the addition of 1 mM
carbamylcholine to a wt AChR.Biophysical Journal 99(3) 798–807
FIGURE 5 Single-channel currents and R/E
plots for position aI49 and aN96. (A) aI49 mutant
AChRs. Left: Example single-channel clusters for
eight mutants, all activated by choline. Right:
R/E plot. All substitutions except Ala increased
the diliganded gating equilibrium constant. The
slope of the line (F) ¼ 0.71 5 0.13. (B) aN95
mutant AChRs. Left: Example single-channel clus-
ters for the W mutant (activated by ACh) and the Q
mutant (activated by choline). Right: R/E plot. The
slope of the line (F) ¼ 0.865 0.03.
804 Cadugan and AuerbachIn addition to having a large range-energy, position aA96
also has the largest side-chain coupling energies between
residues in AChR gating reported to date. With the residue
pairs tested, position aA96 is coupled energetically with
both aY127 and aI49, by ~5.8 kcal/mol each. This means
that the gating equilibrium constant can be nearly 20,000-
fold different from what it would be if the energetic conse-
quences of the mutations were independent. This degree of
interaction indicates that the gating molecular movementsTABLE 2 Coupling energies determined from mutant-cycle analyse
Construct Agonist f SE b SE
A96YþY127A Cho 2690 400 3530 85
A96KþY127E Cho 4680 190 5510 48
A96CþY127C Cho 7760 460 793 9
I49AþA96L Cho 1980 290 6360 43
I49YþA96L Cho 8110 1000 925 14
I49KþA96D Cho 3640 15 1230 1
I49CþA96C ACh 2690 320 3340 41
I49DþY127K ACh 3620 99 8590 110
I49YþY127I ACh 3700 270 9460 18
I49KþY127D ACh 321 34 7830 6
I49CþY127C ACh 5570 250 9930 100
Y93HþA96H None 203 44 8420 190
Y93RþA96H None 124 15 12,200 14
A96NþW149S None 411 5 9380 80
N95WþY127F ACh 12200 1400 2510 2
I49YþN95W ACh 1810 380 4990 59
Column definitions are given in Table 1. Fold-change (observed) is Emutant-pair/Ewt
for each mutant of the pair alone. Rate constants for aY127, aY93, and aW149 m
DDG (kcal/mol), is calculated as described in Materials and Methods. The rang
values (kcal/mol): 96-127 (Y/A-C/C) ¼ 4.9; 96-49 (C/C-Y/L) ¼ 5.4; 49-127 (C
Biophysical Journal 99(3) 798–807(energy changes) of these three positions are strongly
coupled.
We observed that even though 96/127 and 96/49 are
coupled, 127/49 are not (four pairs tested). The degree of
coupling energy between amino acids depends on the nature
of the side-chain substitutions. Because we estimate the
coupling energy only by making mutations of both residues,
one possible explanation for the lack of coupling between
127/49 is that there is none when position 96 is Ala. Anothers
Fold-change
E Observed Predicted DDG n
0 0.76 16.5 169 1.4 3
0 0.85 18.5 0.118 3.0 3
8 9.79 213 0.589 3.5 3
0 0.31 6.77 18 0.6 5
0 8.77 191 468 0.5 5
9 2.97 64.6 65,600 4.1 3
0 0.80 0.029 673 5.9 3
0 0.42 0.015 0.013 0.1 3
0 0.39 0.014 0.009 0.2 4
0 0.041 0.001 0.001 0.0 3
0 0.56 0.020 0.029 0.2 3
0 0.024 36,500 48,200 0.1 3
0 0.010 15,400 8950 0.32 3
0 0.044 66,400 73,300 0.06 3
2 4.88 0.173 0.132 0.16 3
0 0.36 0.013 0.021 0.30 5
and fold-change (predicted) is the product of the fold-changes in E measured
utants can be found in Purohit and Auerbach (21,41). The coupling energy,
e-coupling-energy is the difference between the largest and smallest DDG
/C-D/K) ¼ 0.3.
FIGURE 6 Maps and histograms of range-
energy andF in the a-subunit extracellular domain.
(A) The range-energy is the natural logarithm of the
largest/smallest gating equilibrium constant ratio
for a family of mutations at each position. Blue
spheres:R4.0 kcal/mol; * the approximate position
of the agonist. The largest range-energy residues
approximately form a column that links the
transmitter-binding site (aW149) and the gate
region of the pore-lining M2 helix (aV255).
Bottom: Histogram of range-energy for all of the
residues studied so far in the a-subunit. Residues
in the marked bins: 1), W149, V261, S266, and
I274; 2), V132, I264, and F135; 3), S268 and
P265; 4), V255 and P272; and 5), E45. (B) F is
the slope of the R/E relationship. Residues in the
a-subunit with a range-energy >1.5 kcal/mol are
shown as spheres. Color is according to theF-value
in the histogram (for clarity, residues with F < 0.5
are not shown). aA96 and aP272 are surrounded by
higher-F elements. aA96, aY127, and aE45 have
similar F-values.
Acetylcholine Receptor Gating 805possibility is that the 96 side chain remains essentially unper-
turbed by mutations at 127 and 49, in which case the energy
would not transfer between these two.
The slope of the R/E plot for a family of mutations (F)
gives the extent to which the R4R* reaction has progressed
when the perturbed site experiences its energy change. The
map of F-values (Fig. 6 B) thus provides insight into the
intermediate events as a sequence of events (1-to-0, start-
to-finish). The F-value for aA96 is 0.79 5 0.05, which
indicates that the energy change here occurs fairly early in
the channel-opening process. Other nearby loop A amino
acids, including aY93, aN95, and aD97 (F ¼ 0.86, 0.86,
and 0.93, respectively), appear to move even earlier. Addi-
tional members of this highest-F group include positions
in the general vicinity: the agonist itself (0.91), aW149
(0.82 without agonists and 0.86 with ACh), aY190 (0.88
without agonists), aG153 (0.80 without agonists and 0.96
with choline), and aK145 (0.96 with ACh). The meanF-value for these eight positions (excluding aA96) is 0.90.
We hypothesize that these highest-F positions experience
their gating energy changes at the onset of the forward isom-
erization and before the energy change at positions aA96 and
aY127.
The F-value for aA96 appears to be similar to that for
amino acids in the lower part of the extracellular domain.
This group includes residues that are close to aA96 in struc-
ture and are coupled energetically: aI49 and aY127 (0.71
and 0.77, respectively). Other extracellular domain residues
in this group include four loop 2 residues a45–48 (F ¼ 0.80
(17,19)), the pre-M1 residue aR209 (0.72 (19)), and five
residues in the cys loop (0.77 (32)). The mean F-value
for these 12 residues is 0.77. The pattern of F-values in
the a-subunit extracellular domain suggests that aA96 is at
a boundary between F~0.90 and F~0.77 blocks of residues.
We hypothesize that aA96 gating motions are important for
transferring energy across this block boundary. By the sameBiophysical Journal 99(3) 798–807
806 Cadugan and Auerbachtoken, the gating motion of aP272 (F¼ 0.62) may be impor-
tant for transferring energy across theF¼ 0.77 andF¼ 0.64
block boundary.
The electron density map for the toxin-bound a-subunit
fragment shows that the aY127 side chain can adopt
multiple conformations (23) (Fig. 2 B). In one of these, the
tyrosine hydroxyl moiety is in close contact with aA96.
Further, the Ca2 atom of aI49 is also close to aA96. It is
possible that in the AChR R4R* isomerization, residue
aY127 flips between these alternative conformations, and
this change in position is the basis for the energy transfer
with aA96.
It has been proposed that the R4R* gating in AChRs
involves opposing twisting motions of the extracellular and
transmembrane domains (33,34) and the closure of loop C
over each transmitter-binding site (35,36). Molecular-
dynamics simulations of the prokaryote cys-loop receptor
GLIC suggest that such a global, quaternary conformational
change may involve sequential, tertiary structural rearrange-
ments that propagate between subunits (a so-called domino
mechanism (37)). Our experimental observation that resi-
dues at the a/d/3-subunit interfaces experience large energy
differences in the gating reaction is consistent with calcula-
tions showing that these regions of the protein show sub-
stantial structural perturbations within the quaternary twist
normal mode (38). The strong energy coupling between
positions a96 and a127/a49, the unusual F-value for
aA96 compared to its neighbors, and the alternative electron
densities for position aY127 lead us to further speculate that
the above-mentioned perturbation of each subunit interface
constitutes a pathway for energy transfer through the extra-
cellular domain in AChR gating, as the diffusion of a struc-
tural defect (39,40).
In addition to aA96 and aY127, other significant
members of this energy-transfer chain include (range-
energy in kcal/mol) the binding-site residue aW149 (4.0
(41)), the agonist (10.4 (6)), loop 2 residue aE45 (6.5
(19)), M2-M3 linker residue aP272 (5.5 (32)), M2 cap
amino acids aP268 and aS265 (5.0 and 5.5 (42)), and
aM2-130 residue V255 (5.5 (43)). These nine positions
exhibit the largest range-energy values in the extracellular
domain of the protein (Fig. 6 A, bottom). They also form
a column that spans the regions between the transmitter-
binding site and the gate region of the pore. We speculate
that after a transmitter molecule occupies its binding site,
near-synchronous movements of residues in the immediate
vicinity serve to increase the affinity of the protein for the
agonist. These movements also perturb loop A, causing a
repositioning of aA96, which transfers energy to aY127
and aI49 in loop 2. The detailed mechanisms by which
this perturbation spreads through the a-subunit extracel-
lular-transmembrane domain interface and to the M2 gate
(in all subunits), and the relationship of these structural
rearrangements to larger-scale motions of the protein,
remain to be illuminated.Biophysical Journal 99(3) 798–807SUPPORTING MATERIAL
Threefigures are available at http://www.biophysj.org/biophysj/supplemental/
S0006-3495(10)00607-7.
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